Teleflex Incorporated (NYSE:TFX - Get Free Report) announced a quarterly dividend on Thursday, November 5th. Shareholders of record on Monday, November 16th will be given a dividend of $0.34 per share by the medical technology company on Thursday, December 31st. This represents a $1.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, November 16th.
Teleflex has a payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Teleflex to earn $10.89 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 12.5%.
Teleflex Stock Performance
Shares of NYSE:TFX traded up $1.98 on Thursday, hitting $151.85. 1,417,531 shares of the company were exchanged, compared to its average volume of 784,145. Teleflex has a 1-year low of $100.18 and a 1-year high of $156.67. The stock's 50 day moving average price is $131.62 and its 200 day moving average price is $125.60. The company has a current ratio of 2.60, a quick ratio of 2.12 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $6.43 billion, a P/E ratio of -6.52, a price-to-earnings-growth ratio of 0.94 and a beta of 0.85.
Teleflex (NYSE:TFX - Get Free Report) last released its earnings results on Thursday, November 5th. The medical technology company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.73. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%. The firm had revenue of $567.80 million for the quarter, compared to the consensus estimate of $565.52 million. During the same period in the prior year, the firm earned $3.67 EPS. The firm's revenue was up .1% on a year-over-year basis. Sell-side analysts predict that Teleflex will post 7.22 EPS for the current year.
More Teleflex News
Here are the key news stories impacting Teleflex this week:
Teleflex Company Profile
(
Get Free Report)
Teleflex Incorporated is a global medical technology company that develops, manufactures and markets specialty medical devices. Its products are designed to support healthcare professionals in critical care and procedural settings, including vascular access, interventional cardiology and radiology, anesthesia, respiratory care, emergency medicine, surgical applications and urology.
The company's portfolio includes catheters, access and closure devices, airway-management products, surgical instruments, pain-management devices and other technologies used in hospitals and outpatient facilities.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.